stem cell treatment

Energy OCI to build $265 mn solar cell plant in Texas, expects $80 mn tax credit

South Korean solar cell company OCI Holdings Co. said on Thursday it will build a solar cell manufacturing plant in Texas through its US subsidiary ...

Batteries SK On to supply 100 GWh of EV batteries to Nissan

SK On Co. has landed a deal to supply nearly 100 gigawatt hours (GWh) of electric vehicle batteries to Japanese carmaker Nissan Motor Co., which cou...

Hydrogen economy Hyundai Motor to build fuel cell plant in South Korea

Hyundai Motor Co. will build a local fuel cell plant in South Korea, accelerating its bid to create an entire hydrogen fuel cell value chain in line...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Energy Korea’s OCI, Israel’s Arava Power to jointly build solar cell plant in Texas

OCI Energy Co., a US subsidiary of South Korea’s OCI Holdings Co., and Israel’s Arava Power will jointly build a solar cell power plant ...

Corporate restructuring SK Ecoplant seeks to sell waste treatment business for $1.4 billion

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Mergers & Acquisitions LG Chem embarks on sale of dermal filler business worth $343 million

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Energy Hanwha Q Cells sells two solar power plant projects in US

Hanwha Q Cells Co., a solar panel manufacturing arm of South Korea's Hanwha Solutions Corp., said on Wednesday that it sold its two large-scale sola...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Bio & Pharma Celltrion gets approval of Omlyclo in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

Batteries LG Energy set to acquire GM’s $1 bn stake in Ultium JV plant in Michigan

South Korea’s LG Energy Solution Ltd. plans to acquire General Motors Co.’s stake in their battery joint venture plant in Lansing, Michi...

Energy Hanwha Q cells’ US subsidiary EnFin raises $321 mn through ABS

Hanwha Q Cells Co., the solar power unit of South Korea’s chemicals-to-defense conglomerate Hanwha Group known as Qcells in overseas markets, ...

Batteries LG Energy to supply 2170-type cells to Bear Robotics

South Korea’s LG Energy Solution Ltd. said on Monday it has signed an initial agreement to supply cylindrical battery cells to Bear Robotics I...

Bio & Pharma Celltrion releases Steqeyma in Europe

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

Energy Hanwha Q Cells, OCI to benefit from expanded US CHIPS Act subsidies

South Korean solar cell companies such as Hanwha Q Cells Co. and OCI Holdings Co. are set to benefit from expanded subsidies covered by the US CHIPS...

Energy DS Dansuk wins $750 mn SAF material order from Phillips 66

South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...

Bio & Pharma ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Batteries LG Energy, Stellantis’ EV battery JV in Canada mass-produces modules

LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, said on Wednesday its joint venture in Canada with m...

Batteries LG Energy to supply batteries for Ford's electric commercial vehicles

LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, is set to supply battery cells and modules to US For...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Energy Hanwha Q Cells sells 142 MW solar power plant in Washington

Hanwha Q Cells Co., a solar panel manufacturing arm of South Korea's Hanwha Solutions Corp., said on Wednesday that it sold a 142-megawatt solar pow...

Bio & Pharma Osstem Implant to boost digital dentistry business

South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...

Shipping & Shipbuilding Hanwha unveils carbon-free gas carrier amid tougher rules

Hanwha Ocean Co., South Korea’s third-largest shipbuilder, has introduced a carbon-free gas carrier to meet the growing demand for eco-friendl...

Bio & Pharma Celltrion to supply breast, stomach cancer treatment to Brazil

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Bio & Pharma SK Group’s 3rd-generation daughter comes to the fore

Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...

Hydrogen economy HD KSOE buys Finnish fuel cell maker Convion for $81 mn

HD Hydrogen, a unit of HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), has acquired Convion Ltd, a Finnish hydrogen fuel cell maker,...